+ND Capital — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Orca Bioorcabio.comin 𝕏Nov 2019

Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome.

BiotechDigital HealthHealthtechMedical DevicesCalifornia, US

Jeroen(Co-founder and President)Ivan Dimov(Executive Officer, Director)Nathaniel Fernhoff(Executive Officer, Director)

BoardAlex Kolicich(Director)Jonathan MacQuitty(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.